Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04743297
Other study ID # IRP-2020/01-04
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date March 2021
Est. completion date January 2023

Study information

Verified date February 2021
Source University Medical Centre Maribor
Contact Veronika Anzeljc
Phone + 386 2 321 21 73
Email veronika.anzeljc@ukc-mb.si
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Premature rupture of membranes (PROM) at term is a rupture that occurs at term (> 37 weeks) before the start of labor. The purpose of the study was to compare the safety and efficacy of two agents used in induction of labor in women with term PROM Propess (Controlled release dinoprostone, Vaginal Delivery System) and Prostin E2 (Dinoprostone vaginal Tablet). Women will be randomised to two treatment groups. Although some studies support efficacy of the Propess for cervical ripening at term in induction of labor with intact membranes, it has not been well studied in women with PROM at term.


Description:

The study is going to include all pregnant women with in-term PROM (after week 37 of pregnancy) without contractions if they meet the inclusion criteria. If the cervix is still non-inducible after 4-6 hours and there are no contractions, the medication to be administered to them will be determined by means of computer randomization. The success rate of induction with Propess vs. Prostin tablets will be compared. Soon after PROM, there can be the onset of contractions and cervix dilation that lead to childbirth. In case of some pregnant women, there are no contractions and cervix dilation even after the event despite PROM and water breaking. If the status remains unchanged, the risk of intrauterine infection, fetus infection, and later on an infection of the newborn increases. The expecting mother can also eventually lose hope for a successful vaginal birth and starts thinking about having a caesarean delivery. To avoid that, the investigators use medications that accelerate the onset of vaginal birth in clinical practice. The investigators know several ways to induce labour after PROM. References give no clear and reliable data on the best approach. The investigators can use medications such as oxytocin, dinoprostone, or misoprostol. Our ward has been using Prostin 3 mg (dinoprostone) vaginal tablets to induce labour in case of PROM for several years. They have proven to be an efficient and safe procedure in our clinical practice. Propess is used for the induction of labor with intact membranes. Based on the information from references and according to our experience, the medication is highly effective and safe, as well as easy to use. Our study aims at establishing whether it can also be used with pregnant women with PROM.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 526
Est. completion date January 2023
Est. primary completion date January 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older - Gestational age 37 weeks or more - Singleton pregnancy - Cephalic presentation - Unfavorable cervix (BISHOP <6) - No contraindications for vaginal delivery - Without uterine surgery - Without chorioamnionitis Exclusion Criteria: - Age less than 18 years - Multiple gestation - Previous cesarean section - Suspected intraamniotic infection - Any contraindication to vaginal delivery - Bishop score >7 - Pathological ctg

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Prostaglandin E2 (Propess)
Propess - The vaginal insert is removed 24 h after the application. It is only to be removed earlier in case of the onset of active labour or at the occurrence of hyperstimulation.
Prostaglandin E2 (Prostin)
Prostin - 3 mg vaginal tablet is placed in the posterior vaginal fornix. Dose can be repeated every 8 hours till onset of active labour or the occurrence of hyper-stimulation.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Medical Centre Maribor

References & Publications (12)

Athiel Y, Crequit S, Bongiorno M, Sanyan S, Renevier B. Term prelabor rupture of membranes: Foley catheter versus dinoprostone as ripening agent. J Gynecol Obstet Hum Reprod. 2020 Oct;49(8):101834. doi: 10.1016/j.jogoh.2020.101834. Epub 2020 Jun 22. — View Citation

Cheung PC, Yeo EL, Wong KS, Tang LC. Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstet Gynecol Scand. 2006;85(9):1128-33. — View Citation

Freret TS, Chacón KM, Bryant AS, Kaimal AJ, Clapp MA. Oxytocin Compared to Buccal Misoprostol for Induction of Labor after Term Prelabor Rupture of Membranes. Am J Perinatol. 2021 Feb;38(3):224-230. doi: 10.1055/s-0039-1696642. Epub 2019 Sep 6. — View Citation

Geethanath RM, Ahmed I, Abu-Harb M, Onwuneme C, McGarry K, Hinshaw K. Intrapartum antibiotics for prolonged rupture of membranes at term to prevent Group B Streptococcal sepsis. J Obstet Gynaecol. 2019 Jul;39(5):619-622. doi: 10.1080/01443615.2018.1550474. Epub 2019 Mar 27. — View Citation

Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, Wang EE, Weston JA, Willan AR. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996 Apr 18;334(16):1005-10. — View Citation

Hu YP, Zhou D, Li M, Wang Y, Wang L, Sun GQ, Xiao M. Use of labor induction with dinoprostone vaginal suppositories in pregnant women with gestational hypertension. J Obstet Gynaecol Res. 2019 Nov;45(11):2185-2192. doi: 10.1111/jog.14092. Epub 2019 Aug 27. — View Citation

Ivars J, Garabedian C, Devos P, Therby D, Carlier S, Deruelle P, Subtil D. Simplified Bishop score including parity predicts successful induction of labor. Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:309-14. doi: 10.1016/j.ejogrb.2016.06.007. Epub 2016 Jul 5. — View Citation

Mynarek M, Bjellmo S, Lydersen S, Strand KM, Afset JE, Andersen GL, Vik T. Prelabor rupture of membranes and the association with cerebral palsy in term born children: a national registry-based cohort study. BMC Pregnancy Childbirth. 2020 Jan 31;20(1):67. doi: 10.1186/s12884-020-2751-3. — View Citation

National Collaborating Centre for Women's and Children's Health. National Institute for Health and Care Excellence: Clinical Guidelines. Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. London: National Institute for Health and Care Excellence (UK) Copyright (c) 2014 National Collaborating Centre for Women's and Children's Health.; 2014

Pajntar M, Lucovnik M. Normalni porod in vodenje poroda. v knjigi Nosecnost in vodenje poroda. Ured. Pajntar M, Novak Antolic Ž, Lucovnik M. Medicinski razgledi 2015. Tretja dopolnjena izdaja. 231-50.

Shirley M. Dinoprostone Vaginal Insert: A Review in Cervical Ripening. Drugs. 2018 Oct;78(15):1615-1624. doi: 10.1007/s40265-018-0995-2. Review. — View Citation

Zlatnik FJ. Management of premature rupture of membranes at term. Obstet Gynecol Clin North Am. 1992 Jun;19(2):353-64. Review. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Induction to Delivery Interval 24 hours
Primary Induction to Onset of labor Interval 24 hours
Secondary Frequency of Cesarean Sections 24 hours
Secondary Frequency of Failed Induction 24 hours
See also
  Status Clinical Trial Phase
Completed NCT02242214 - REgistry of MisOprostol 200 µg Vaginal dElivery System N/A
Recruiting NCT04163744 - Effectiveness and Safety of Induction of Labour Using a Double Balloon Catheter (INDOBA)
Terminated NCT02932319 - Outpatient Foley Catheter for Induction of Labor in Nulliparous for Prolonged Pregnancy N/A
Not yet recruiting NCT04887493 - To Study the Efficacy and Safety of Misoprostol by Sublingual Routes for Induction of Labour N/A
Completed NCT04454346 - Double Foley Catheter For Cervical Ripening N/A
Completed NCT00299754 - Trial Of Misoprostol And Dinoprostone Vaginal Pessaries for Cervical Priming (TROMAD Study) Phase 3
Completed NCT04477226 - Transvaginal Ultrasound As Predictors of Successful Induction of Labour
Completed NCT03355040 - Induction of Labour for LGA fœtus in Women Without Insulin-treated Diabetes.
Completed NCT03489928 - Misoprostol Labour Induction Study Phase 3